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ABSTRACT  Variants of the  mouse embryo fibroblast  x  melanoma  hybrid  clone  100A have 
been  isolated by a  procedure  that  selects against cells that  are able  to  grow in  medium 
containing  low concentrations  of serum plus insulin. Three variant clones derived  from this 
selection were found to have a much higher serum requirement than the parental clone 100A 
cells, as evidenced  by a very low rate of DNA synthesis and growth in medium containing low 
concentrations  of  serum. Two  of  the  variants had  approximately  double  the  number  of 
chromosomes  as the  parental  cell  line,  while one  had approximately  the  same number of 
chromosomes  as the  parental  cells. One of the variants was very  strongly  reverted  by  5- 
azacytidine but not by ethyl methanesulfonate, suggesting that it reverted by a nonmutational 
mechanism such as a stable change in DNA methylation.  Analysis of the growth requirements 
in  hormone-supplemented  serum-free  media of the  100A parent, the  INS 471  variant,  and 
revertants  of the  variant  indicated  that the  variant  had  a specific  deficiency  in  its  growth 
response to platelet-derived  growth factor (PDGF). PDGF dose-response curves obtained with 
the  variant  cells were shifted  approximately  an  order  of  magnitude  toward  higher  PDGF 
concentrations  relative to PDGF dose-response curves obtained  with the parental 100A cells. 
This quantitative  increase in PDGF requirement of the INS 471 variant appears to explain the 
increased serum requirement of this variant. Equilibrium  binding experiments performed  with 
12sI-PDGF suggest that the variant does not have a decreased number of PDGF receptors. 
Serum contains a complex mixture of  nutrients and hormonal 
growth factors that stimulates the proliferation of  mammalian 
cells. Included among the constitutents of this mixture are 
platelet-derived growth  factor  (PDGF)  t  (1-5),  insulin-like 
growth factors (6-9), steroids (10,  11), transforming growth 
factor-/~ (12),  the ion transport protein transferrin (13,  14), 
fibronectin (15),  cell-spreading factor (16),  lipids (17),  and 
low molecular weight nutrients (18,  19). An early observation 
regarding the oncogenic transformation of normal fibroblasts 
(20,  21) and fibroblastic cell lines (21-23) by tumor viruses 
was that malignantly transformed cells required lower con- 
centrations of serum  for growth than their untransformed 
1  Abbreviations used in this paper:  5-azaC, 5-azacytidine;  EGF, ep- 
idermal growth factor, EMS, ethyl methanesulfonate; FBS, fetal bo- 
vine serum; MEM, Eagle's minimal essential medium; PDGF, plate- 
let-derived  growth factor: SV40, simian virus 40. 
counterparts. More recent results suggest that this quantitative 
decrease in  serum  requirement is  a  distinct event along a 
multistep pathway for conversion of normal somatic cells to 
tumor  cells  (see  for example  references 21  and  24).  The 
reduction in serum  requirement of transformed fibroblasts 
has recently been traced to a loss or reduction in requirement 
for specific growth factors such as PDGF, epidermal growth 
factor (EGF), fibroblast growth factor, or insulin (25-31). The 
identity of genes involved in the control of cell proliferation 
by serum growth factors is a subject of considerable current 
interest. We have recently undertaken a detailed study of the 
growth characteristics of the mouse embryo fibroblast x  mel- 
anoma hybrid clone  100A, which exhibits a  strong growth 
response to insulin and the insulin-like growth factor MSA 
(32-36). We report here the isolation of  variants of  this hybrid 
clone that  have a  markedly increased serum  requirement. 
One of the variants appears to have a specific deficiency in its 
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frequency by 5-azacytidine (5-azaC). 
MATERIALS  AND  METHODS 
Cells, Culture Procedures, and Materials:  Cells  were grown at 
37°C in Eagle's minimal essential medium (MEM) with 10% fetal bovine serum 
(FBS) (from Reheis Chemical Co. [Kankakee, IL], Gibco Laboratories  [Grand 
Island, NY], or Centaurus),  penicillin (71  U/ml), and streptomycin  (100 ug/ 
ml) under a humidified atmosphere containing 95% air plus 5% COz. Cell sizes 
were determined with a Coulter counter (Coulter Electronics Inc., Hialeah, FL) 
equipped  with a channelizer.  Hybrid  clone  100A is a biparental  hybrid  that 
was derived from a fusion between an HPRT- clone of a spontaneous mouse 
melanoma and secondary  mouse embryo cells. The origin,  karyology, and 
growth properties of hybrid clone 100A have been described in detail (32-37). 
PDGF,  purified through the CM Sephadex step of Antoniades et al. (38), was 
obtained  from Collaborative  Research  Inc.  (Lexington,  MA).  The  specific 
activity of the PDGF was 6.6-17  ug/U in the lots used in these experiments. 
(For the definition of PDGF units, see reference 38). This preparation of  PDGF 
was used for growth assays. More highly purified preparations  of PI~F were 
used for recelator binding assays (see below). Porcine insulin (25.5 U/ms) was 
obtained  from Elanco Products  Co. (Indianapolis,  IN). EGF (receptor grade) 
was from Collaborative Research Inc. Human fibronectin was purchased from 
Meloy  Laboratories  Inc.  (Springfield,  VA)  or Collaborative  Research  Inc. 
Soybean trypsin inhibitor (type I-S, chromatographically prepared), transferrin 
(substantially iron free), and BSA (crystalline) were from Sigma Chemical Co. 
(St. Louis, MO). 
Isolation of Variants:  An  exponential  culture  of  100A cells was 
exposed to 650 ug/ml ethyl methanesulfonate  (EMS) for 18 h and grown for 
8 d  (three passages at a  1:4 dilution)  to permit the expression of mutations. 
This concentration  of EMS gave 80% killing as determined  by relative cloning 
efficiencies and more than a  50-fold induction  of ouabain-resistant  variants. 
(In a test for resistance to i  mM ouabain,  the frequency of resistant colonies 
was 1. l x  l0  -~ for unmutagenized cultures and 6 x  l0  -5 for the second passage 
of a mutagenized culture.) 
The mutagenized  cultures of 100A were subjected to four to seven rounds 
of a  negative  selection  procedure  modified  from that  used  by  Pruss  and 
Herschman (39) to select for EGF-unresponsive  variants of the 3T3 cell line. 
For the first round,  10  e cells were plated  per 25  cm  2 tissue culture  flask in 
MEM with 2% FBS. After 24 h, the medium was changed to MEM with 0.3% 
FBS. After a further incubation  of 24 h, when there were few mitotic cells, the 
medium was aspirated  and MEM with 0.3% FBS, coichicine (3 vg/ml), and 
insulin ( 10/~g/ml) was added after filtration (Gelman Acrodisc, 0.2/~m, Gelman 
Sciences, Inc. Ann Arbor, MI). The cultures were permitted to grow for 3--4 d. 
The cultures  were shaken vigorously to remove mitotic  cells and rinsed once 
with PBS. MEM with  10%  FBS was then added  for growth of the survivors. 
After 2-7 d the survivors were trypsinized, seeded into new flasks with MEM 
with 10% FBS, and permitted to reach a density just below confluence at which 
time the cultures were again switched into MEM with 0.3% FBS and a new 
cycle of  the selection begun. In the early rounds of the selection the killing was 
extensive. Control experiments showed that one round of  selection with insulin 
killed 95% of  the cells. The selection was terminated  when it appeared that the 
degree of killing had greatly droplx~l. The surviving cells were plated at donal 
density.  Individual  clones were picked  and named systematically with three 
letters followed by three digits, e.g., "INS 456" means the sixth clone from the 
fifth bottle that underwent four rounds of the selection. 
Measurement of DNA Synthesis by Autoradiography:  Cells 
(60,000 per well) were plated in Linbro trays (How Laboratories, McLean, VA) 
with 24 wells, each containing  one 1.5-cm coverslip in l ml of medium. DNA 
synthesis was measured by adding  [3H]thymidine to the medium at a  final 
concentration  of 5 #Ci/ml (6.25 ×  10  -8 M). Coverslipa were fixed as described 
(40), mounted on glass slides, dipped in NTB-2 (Kodak) emulsion, exposed for 
24 h,  and developed  according  to  manufacturer's instructions.  Nuclei  were 
stained  for 50 rain with 4% Giemsa stain  (Fisher Scientific Co., Pittsbmgh, 
PA) in 0.07 M  sodium phosphate buffer, pH 7.0. At least 400  nuclei were 
counted in a minimum of five fields for each coversllp. 
Determination of Chromosome  Number:  An  exponentially 
growing culture  was exposed to Colcemid  (0.1-0.2  ;tg/ml)  for 25-30 rain to 
collect mitotic cells. Cells were allowed to swell in 0.56% KCI for 10 rain, fixed 
twice with  methanol/acetic  acid  (3:1), and  spread  on cleaned  slides. After 
staining with 4% Giemsa in 0.07 M sodium phosphate, pH 7.0, 50 metaphase 
chromosome spreads were counted under x  1,250 magnification. 
Reversion Analysis:  Exponential cultures were exposed to EMS or 5- 
azaC  in MEM  plus  10%  FBS for 24 h  at  37°C. Parallel  untreated  control 
cultures  were inehided  in each experiment.  The medium was then removed 
and the cultures  were washed  once  with  PETS. Survival was determined  by 
trypsinizing some cultures and plating cells at densities of 100 and 1,000 cells 
per 10-cm dish in MEM plus 10% FBS. Colonies on these dishes were scored 
at 1 wk by fixing cells and staining with 0.1% crystal violet. Fresh medium was 
added to other mutagen-treated and control cultures, and the cells were allowed 
to grow to confluence (48 h at 37°C). The cultures were then subcultJred at a 
1:4 dilution, to allow recovery from the mutagen. After the cells had grown to 
confluence (3--6 d), cells were trypsinized  and plated at a density of 104 cells 
per 10-cm dish in MEM plus 0.3% FBS, or 106 cells per 10-cm dish in MEM 
containing  10%  FBS and  10  mM ouabain.  In some experiments,  forward 
mutation rate to ouabain resistance was measured by plating cells at 105 cells 
per 10-cm dish in MEM containing  10% FBS and 1 mM ouabain.  Mutation 
frequencies obtained  by this method agreed closely with  those  obtained  by 
plating cells at 106 cells per 10-¢m dish in medium with 10 mM onabain.  At 
the higher plating density, the higher onabain concentration  was required  to 
suppress growth of the background.  Revertant  colonies capable of growing in 
medium with 0.3% FBS were fixed, stained, and counted after 3 wk. Ouabain- 
resistant colonies that had diameters >3 mm were scored after 2 wk. 
Growth  of Cells in  Hormone-supplemented  Serum-free 
Media:  The basal serum-free medium consisted of  a  l:l mixture of Ham's 
FI2 medium and Dulbeeco's  modified  Eagle's medium,  1.2 g/liter sodium 
bicarbonate (Oibco Laboratories, tissue culture grade), 15 mM HEPES (Calbi- 
ochem Ultrol  grade  [Calbiochem-Behring  Corp.,  La Jolla,  CA]),  15  uM 2- 
aminoethanol  (Sigma Chemical Co.),  100 ug/ml streptomycin  (Calbiochem), 
and 71 U/ml penicillin (E. R. Squibb & Sons, Princeton,  NJ), adjusted to pH 
7.3. The medium and all solutions used in the serum-free growth experiments 
were made up in high-performance liquid chromatography-grade  water (Fisher 
Scientific Co.). Basal medium was stored at 4"C for periods up to 1 mo before 
use. Immediately before use, the medium was supplemented  with 3 x  l0 -8 M 
H2SeO3, and, as indicated, fibroneetin (10/~g/ml), transferrin (5 ug/ml), insulin 
(5 ug,/ml), PDGF (0.5 U/ml), or EGF (200 ng/ml). Some batches of PDGF 
were found to contain cytotoxic contaminants.  To eliminate these, we routinely 
heated the PDGF to 100"C for l0 rain before use. 
For serum-free growth experiments,  a log-phase culture  in a 75 cm  2 flask 
was washed two times with 15-20 ml ice-cold (4"C) PBS. At t = 0,  l0 ml of 
ice-cold trypsin  (0.5% in PBS) was added.  At  t  =  1 rain,  the trypsin  was 
aspirated and incubation  was continued  at room temperature.  At t = 2.5 rain, 
the flask was shaken to dislodge the cells, and l0 ml of  ice-cold soybean trypsin 
inhibitor (1 mg/ml in PBS) was added. Cells were washed once with unsupple- 
taunted  serum-free medium, rcsuspended in the same medium, counted,  and 
plated at a density of 10,000 cells per 3.5-cm dish. After 3-4d at 37°C, ceils 
were removed by trypsinization  and counted with a Coulter counter. 
PDCF Binding Assays:  Cells were grown to confluency  in 3.5-cm 
dishes in MEM plus 10% FBS, washed twice with 2 ml of serum-free MEM, 
and incubated at 37"C for 1 h with 2 ml of serum-free MEM. The MEM was 
aspirated and replaced with 1 ml binding mix, which consisted of PBS plus 10 
,g/ml MgSO4.7 H20,  10 ~g,/ml CaC12.2 H20, l mg/ml BSA, 100,000 cpm of 
homogenous ~251-PDOF (specific activity 20,000 cpm/ng, generously provided 
to us by Dr. Harry Antoniades), with or without 500 ng/ml of  partially purified 
PDGF (purified through the blue Sepharose step  [41]; also provided  by Dr. 
Antoniades).  The  binding  assays were  incubated  at  4"C  for 3 h,  and  the 
monolayers  were then rapidly  washed six times with  2  ml of ice-cold PBS 
containing  1 mg/ml BSA. The cells were solubilized with 2 ml of 10% glycerol 
and  1% Triton X-100, and radioactivity  was determined  in a Beckman Bin- 
gamma counter (efficiency 78%; Beckman Instruments Inc., Irvine, CA). All 
results  represent  the average of triplicate  determinations.  Cell counts were 
performed on triplicate parallel cultures using a Coulter counter. 
RESULTS 
Variant Isolation 
Clone  100A  is  a  mouse embryo fibroblast  x  melanoma 
hybrid cell line that exhibits  a very strong growth response to 
insulin and the insulin-like  growth factor MSA (33-36). Our 
aim  was to  select  for variants  of this  cell  line  that  had  a 
reduced response to the mitogenic action of insulin by stim- 
ulating growth-arrested cells with insulin in the presence of 
colchicine and  removing cells  that entered  into  mitosis  in 
response to the hormone (see Materials  and Methods). A total 
of 37 clones were isolated from cells that survived between 
four and seven rounds of  selection. These clones were screened 
for ability to respond to the stimulatory effect of insulin in 
the [3H]thymidine incorporation assay (performed as in ref- 
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resistant to the growth-stimulatory effects of insulin, several 
clones differed  dramatically from the parental  clone  100A 
cells in that they arrested growth much more completely in 
medium with low serum than did the parental cells.  These 
clones represented 16% of clones that survived the selection. 
Three  variant  clones of this  class  were  chosen for  further 
study. 
Chromosomal analysis  (Fig.  1)  revealed that two  of the 
variants had approximately double the number of chromo- 
sprees observed in the parental clone 100A cells (INS 471 and 
INS 794),  while one variant (INS 643)  had a median chro- 
mosome number very close to that of done  100A. None of 
the three variant clones were resistant to colchicine (Table I). 
Serum and Growth  Factor Response of Variants 
As shown in Table II, the three variant clones were strongly 
serum  dependent  in  comparison  with  the  parental  clone 
100A,  which was capable  of slow growth in  medium with 
0.3%  FBS. The generation times observed for the variants in 
medium  with  10%  FBS  were  approximately  equal  to  the 
generation time of the parental cells. This indicated that the 
variants were  not  simply  slow growers,  but  rather had  an 
increased serum requirement. The parental clone  100A cells 
had  a  relatively  high  saturation density,  while that  of the 
variants was much lower (Table II), This may also reflect an 
increased serum requirement of the variants (e.g., see refer- 
ence 42). 
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RGURE  1  A frequency distribution of chromosome counts for each 
of the variants was determined  by counting at least  50 well-sepa- 
rated  metaphase spreads. The  arrows  indicate  the  median  of the 
distribution. 
TABLE  I 
Colchicine Resistance of Variant Cells 
Number of colonies* 
Colchicine  100A  INS 471  INS 643  INS 794 
#glml 
0.00  113  59  77  126 
0.01  99  53  71  62 
0.10  0  0  0  0 
1.00  0  0  0  0 
I 0.00  0  0  0  0 
* Cells were plated at 200 cells per 10-cm dish in MEM with 10* FBS with 
the indicated concentrations of colchicine. After  10 d the colonies were 
stained with  crystal violet  and  counted.  Each point was  an  average of 
duplicates. 
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The response of the variant clones to insulin and serum in 
nuclear labeling experiments is shown in Fig.  2.  The basal 
level of nuclear labeling in the variant clones in medium with 
low serum was much lower than that of the parental cells, 
reflecting the more  complete growth arrest of the  variants 
under these conditions. Addition of 1% FBS to resting cultures 
of the variant clones recruited only a very small fraction of 
cells  to  enter  S  phase,  while  the  same  amount  of serum 
strongly stimulated the parental cells (Fig. 2, bar F). Addition 
of 10%  FBS to resting cultures of the variant clones caused 
most cells to enter S phase. These results again demonstrate 
the increased serum requirement of the variants relative to 
that  of the  parental  clone  100A  cells.  All  of the  variants 
exhibited a response to insulin in the nuclear labeling assay 
(Fig. 2, bars B and C). However, in each case the total fraction 
of cells that entered S phase in medium with low serum plus 
insulin was considerably lower than  for the parental  cells. 
TABLE  II 
Growth Parameters and Size of the Variants 
Cell line 
Mean generation 
time* 
Saturation 
0.3% FCS  10% FCS  density*  Size  s 
h  cells/cm  2 x 
10-5  p,m  3 
100A  55  14.9  1.20  1,160 
INS 471  >100  15.7  0.43  2,140 
INS 643  >100  14.6  0.68  1,160 
INS 794  >100  15.0  0.43  1,670 
* Cells were plated at 100,000-200,000  cells per 6-cm tissue culture dish in 
the  indicated  medium.  Duplicate  dishes were  trypsinized and  counted 
daily. Growth rates were calculated in a period of exponential growth from 
day 1 to day 3. 
f Saturation densities were determined in medium with 10% FCS. 
t Cell sizes were determined with a Coulter counter equipped with a chan- 
nelizer. 
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FIGURE  2  Rate of DNA synthesis  was determined  by autoradiog- 
raphy as described in Materials and Methods in response to insulin, 
PDGF,  or serum.  Cells  were  plated  on  coverslips  at  a  density  of 
60,000 cells per 1.5-cm well in MEM, supplemented with 0.3% FBS 
in  1 ml,  and  incubated  for  3 d  at 37°C.  At this time,  stimulatory 
factors  and [3H]thymidine were added in MEM (20 ,I) as indicated. 
24 h after the addition of the  stimulatory  factors  and labeled  thy- 
midine, the cells  were fixed  and the  percentage  of labeled  nuclei 
was determined as described in Materials and Methods. (A) Control; 
(B) +  1 #gJml insulin; (C) +  10 ~gJml insulin; (D) +  1 UJml PDGF; 
(E) +  1 U/ml  PDGF +  10 ~g/ml  insulin;  (F)  +  1% FBS; (G) +  10% 
FBS. This explains the selective advantage of the variants under 
the conditions used for their isolation. 
Since higher concentrations of serum were required to elicit 
a growth response in the variants than in the parental clone 
100A cells, we examined the response of the variant clones to 
PDGF,  which  is one  of the  principal  mitogenic factors in 
serum  (1,  2).  Dose-response curves for stimulation  of the 
parental 100A and variant cells with PDGF are shown in Fig. 
3. The parental clone  100A  cells exhibited a  strong growth 
response to PDGF, while the response of the variant clones 
to PDGF was very weak. As with insulin, the total fraction of 
cells that entered S phase in response to PDGF was high for 
the clone 100A cells and low for the variants. In experiments 
in which high concentrations of  PDGF and insulin were added 
together to the variants, we observed a stimulation that was 
more  than  the  sum  of the  individual  effects  of the  two 
hormones (Fig. 2, bars C, D, and E). This suggests synergism 
in the effects exerted by the two hormones, similar to that 
observed with other cells (43, 44).  However, even the combi- 
nation of a high concentration of insulin and PDGF induced 
<50%  of the variant cells to enter S phase during the 24-h 
labeling period. In contrast to the results obtained with the 
variant cells, a less than additive effect of insulin and PDGF 
was observed with the parental clone 100A cells, since either 
hormone alone was strongly stimulatory to the parental cells. 
Reversion Analysis 
The  increased  serum/growth  factor  requirement  of the 
variants was also manifested in an inability to form colonies 
capable of sustained  growth  in  MEM  with  1%  FBS.  The 
parental clone 100A cells formed large, rapidly growing clones 
in this  medium (13-22%  cloning efficiency). INS 643  and 
INS 643 
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FIGURE  3  Effect of PDGF on DNA synthesis in 100A, INS 643, INS 
471, and INS 794. Cells were plated on coverslips at a density of 
60,000 cells per 1.5-cm well in MEM, supplemented with 0.3% FBS 
in  1  ml,  and  incubated  for  3 d  at  37"C.  At this  time  PDGF  and 
[3H]thymidine were added in MEM (20/~1) as indicated. 24 h after 
the addition of the  PDGF  and  labeled thymidine,  the cells were 
fixed  and  the  percentage  of  labeled  nuclei  was  determined  as 
described in Materials and Methods. 
INS 794  formed minute clones in this medium, while INS 
471 did not form clones at all (Fig. 4). This difference between 
the parental cells and variants was specific for medium with 
low serum; in MEM containing  10% FBS,  the variants and 
parental cells both formed clones with high efficiency (40- 
70%  cloning efficiency). The  variant  that  gave the  lowest 
background growth in  medium with  low serum (INS 471) 
was selected for further analysis. 
The  background  of growth  of the  INS  471  variant  in 
medium  with  low  serum  was  sufficiently low  that  it  was 
possible to select for revertants of this variant that were able 
to grow in medium with low serum (LS  + revertants) by plating 
the  variant at a  low density 004  cells per  10-cm dish)  in 
medium with 0.3-1% FBS (Table III). Interestingly, the base 
analogue 5-azaC caused the variant to revert to LS  ÷ at a very 
high frequency (~ 1%). In contrast, the alkylating agent EMS, 
which is a strong mutagen, was relatively ineffective in rev- 
erting the variant. The mutagenic activity of EMS and 5-azaC 
in the same cells has been examined in parallel experiments 
in which forward mutation to ouabain resistance (45-47) has 
been  measured.  EMS,  but  not  5-azaC,  induced  ouabain- 
resistant mutants of the INS 471  cell line. This is consistent 
with the known relative mutagenic potency of the two com- 
pounds as measured in other systems: EMS is a very strong 
mutagen (48, 49) and 5-azaC is a very weak mutagen (50). 5- 
azaC  is  known  to  cause  undermethylation  of  DNA  and 
reexpression of genes that  have been  inactivated  by DNA 
methylation (51-55).  The very high  reversion frequency of 
INS 471  induced by 5-azaC suggested that 5-azaC reverted 
INS 471 via a nonmutational mechanism such as a change in 
DNA methylation. 
To determine whether the LS  ÷ phenotype of the revertants 
was stable, four 5-azaC-induced LS  + revertants of INS 471, 
were picked, cultured in MEM plus  10% FBS,  and replated 
at clonal density in MEM and  1%  FBS.  All four revertants 
were able to form large clones in MEM plus  1% FBS, indi- 
cating that the LS  ÷ phenotype was stable. The cloning effi- 
ciency of the revertants in this medium ranged from 3-14%, 
as  compared with  a  cloning efficiency of  13-22%  for the 
parental hybrid clone 100A cells in the same medium. 
Growth of IOOA and INS471 in Hormone- 
supplemented Serum-free Media 
The  analysis  of the  growth  response  of the  variants  to 
insulin and PDGF shown in Figs. 2 and 3 involved short term 
stimulation (24 h) in medium that contained a low concen- 
tration of serum. These experiments were complicated by the 
presence  of PDGF  and  insulin-like  growth  factors  in  the 
serum. The growth response of the parental  100A  cells, the 
INS 471  variant, and two independent LS  + revertants of INS 
471  to PDGF and insulin was studied  further under com- 
pletely serum-free conditions.  The parental  100A ceils grew 
extremely well in a  serum-free medium supplemented with 
fibronectin, transferrin, insulin, and PDGF (Fig. 5, bar D). In 
this  medium,  a  74-fold increase  in  cell  numbers  over the 
inoculum was observed with the 100A cells: this corresponds 
to a generation time of ~14 h. This is one of the most rapid 
growth rates ever observed for any cell line in any hormone- 
supplemented serum-free medium (56), and it is as fast as the 
growth rate of the  same cells in  medium with  10%  serum 
(Table II). In the same medium in which PDGF was replaced 
by EGF, good growth was also obtained, although less growth 
STRAUS AND COPPOCK  Variant  Cells With High Serum Requirement  1841 FIGURE  4  Cells were plated at a density of 1,000 per 10-cm dish in MEM that contained 1% FBS. The dishes were incubated at 
37"C for 12 d and colonies were then fixed and stained with 0.1% crystal  violet. (A) Clone 100A; (B) INS 643,  (C) INS 794; (D) 
INS 471. 
was obtained in  the  medium with  EGF than  in  that  with 
PDGF. The growth response of the INS 471  variant cells to 
PDGF and EGF was also examined under serum-free condi- 
tions (Fig. 5). Interestingly, the growth response of  the variant 
cells to PDGF was drastically reduced relative to that of the 
100A cells: there was an approximately 15-fold reduction in 
cell yield in response to PDGF with the INS 471  variant as 
compared with the  100A  parent.  In contrast,  the  INS 471 
variant grew about as well as the  100A parent in the serum- 
free medium supplemented with EGF (Fig.  5, bar E). Thus 
the variant exhibited a  specific deficiency in its response to 
PDGF. No significant difference was observed in the growth 
response of the parental  100A  and INS 471  variant cells to 
insulin. For example, in the experiment illustrated in Fig. 5, 
addition of  insulin to the basal medium containing fibronectin 
and  transferrin  allowed  both  cell  lines  to  maintain  their 
inoculum density, but no net growth was observed in either 
case  (Fig.  5,  bars  B  and  C).  The  results  of these  growth 
experiments performed in serum-free medium thus indicated 
a  specific deficiency of the variant cells in their response to 
PDGF. 
To determine whether the revertants of INS 471 that were 
selected for ability to grow in medium with low serum had 
also reverted for their response to PDGF, we grew two inde- 
pendent  5-azaC-induced LS  ÷ revertants of INS 471  in  hor- 
mone-supplemented  serum-free  medium  under  conditions 
identical to those used for the  100A and INS 471  cells in the 
experiment shown in Fig. 5. The results (Fig. 6) indicated that 
the two LS  + revertants had a  significantly increased growth 
response to PDGF compared with that of  the INS 471 variant. 
In addition, both LS  ÷ revertants resembled the parental 100A 
cells in that the growth obtained in medium with 0.5 U/ml 
PDGF was greater than that obtained in medium with EGF. 
These results indicate that reversion to a high PDGF response 
occurs concomitantly with reversion to LS  +. 
To further analyze the deficiency of the INS 471  variant in 
its response to  PDGF, we performed dose-response experi- 
ments in which growth was measured as a function of PDGF 
concentration (Fig.  7).  The yield of cells obtained with the 
INS 471 variant was lower than that obtained with the paren- 
tal  100A cells at every PDGF concentration tested, whereas 
the response of the INS 471  cells to EGF (200 ng/ml) was 
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Reversion of INS 471 to Growth in Medium with Low Serum 
Oua  r 
Treatment*  Survival*  LS  + Clones  !  Clones  I 
#g/ml  %  per 104 cells  per 106 ceils 
None (control)  (100)  0  0 
EMS 
200  42  0  42 
4OO  22  2  78 
650  0.6  0  29 
5-azaC 
0.03  110  0  0 
0.1  110  0.33  0 
0.3  54  0.33  0 
1.0  54  16  0 
3.0  25  86  0 
10.0  22  12  0 
* Cells were treated for 24 h as described in Materials and Methods. 
Numbers represent the ratio of cloning efficiency of cells from mutagen- 
treated versus control cultures.  The control cloning efficiency was 67% 
(average of six  dishes). Each number for  the  mutagen-treated  cultures 
represents the average of three dishes. 
J Cells were subcultured  once after treatment with mutagen and then plated 
at a density of 104 cells per lO-cm dish in MEM plus 0.3% FBS, The control 
represents the average of six dishes; the  numbers  for  mutagen-treated 
cultures represent the average of three dishes. 
t Cells were subcultured  once following treatment with mutagen and then 
plated at a density of 106 cells per lO-cm dish in MEM plus 10% FBS +  10 
mM ouabain. Results represent the average of duplicate dishes. 
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actually slightly better than  that  of the  100A  cells (Fig.  7, 
broken line).  This again illustrates the specificity of the defect 
in the PDGF response of  the variant. The dose-response curve 
of the variant was clearly shifted to the right relative to that 
obtained with the 100A cells. For any given growth response, 
approximately one order of magnitude higher PDGF concen- 
tration was required by the INS 471 variant than by the 100A 
parent. For example, a yield of 200,000 ceils (corresponding 
to a generation time of ~17 h) was obtained with the  100A 
cells at a PDGF concentration of 0.1  U/ml versus 1.0 U/ml 
for the variant. This shift in the dose-response curve for PDGF 
very likely explains the increased serum requirement of the 
variant. 
PDGf-receptor Binding Experiments 
A possible explanation that we have considered for the poor 
growth response of the INS 471  variant to PDGF is that this 
variant might have reduced numbers of PDGF receptors, and 
that the revertants might have reverted for receptor expres- 
sion. To test this possibility, we performed equilibrium bind- 
ing experiments in which we examined the binding of '25I- 
labeled PDGF to the parental 100A cells, the INS 471 variant 
cells,  and  one  LS  + revertant of the  INS 471  variant.  The 
results (Table IV) indicated that all three cell lines exhibited 
STRAUS AND COPPOCK  Variant  Cells With High Serum Requirement  1843 fOT 
tO  6 
•  ~.  10 5 
J 
J 
i,i 
10 4 
I  1  I  I  I  I  I 
A 
I  i  I 
A 
v 
107 1 
I 
1 
io6[ 
[ 
t 
r 
~'-- tOS I 
d 
10  4 
q 
tO3 l 
IlO  0 
i  1  i  i  i  1  i  i  i  i 
B 
io 3  ~  L  o  o  ~  ~.  ~  i  °  i  t  i  t  t  t  ,  l  t  t 
0  01  02  3  .4  05  06  07  08  9  O.I  0.2  0.3  04  0.5  0.6  07  0.8  0.9  I.O 
[POGF]  U/ml  [POGF]  U/m, 
Fioure  7  PDGF  dose response curves for the parental 100A cells (A), and INS 471 variant cells (B). Cells were plated at a density 
of 10,000 cells per 3•5-cm dish in basal serum-free  medium supplemented with 10 #g/ml fibronectin, 5/~g/ml transferrin,  5 #g/ 
ml insulin,  and PDGF as indicated. Each point represents the average of duplicate determinations. (- • -)  Represents growth 
obtained in basal  serum-free  medium supplemented with 10 #g/ml fibronectin, 5 p,g/ml transferrin,  5 #g/ml insulin, and 200 ng/ 
ml EGF (average of duplicate determinations). 
TABLE IV 
Binding of PDGF to Clone 100A, INS 471, and INS 471  LS+I 1 
Cells  Total binding  Nonspecific binding  Specific binding  Specific binding 
cprnldish  cpmldish  cpm/dish  cpmlIO  s cells 
100A (parent)  4,226 +_ 870  1,450 +  149  2,776  145 
INS 471 (variant)  4,617 _+ 1,076  1,534 _+ 144  3,083  548 
INS 471 LS+I 1 (revertant)  4,302 +_ 402  1,863 -  438  2,439  439 
specific binding of PDGF. Normalizing the data to cell num- 
bers, the INS 471  variant actually bound more PDGF than 
the parental 100A cells. The variant cells have approximately 
1.5-fold more surface area than the 100A parent cells (Table 
II); however, this difference in surface area does not account 
for  the  greater  than  threefold  increase  in  specific  PDGF 
binding observed with the variant. In any case, these results 
suggest that the diminished PDGF response of the INS 471 
variant  is  not  attributable  to  decreased  number of PDGF 
receptors having an unaltered affinity for PDGF. 
DISCUSSION 
The selection procedure used to isolate the variants was based 
on removal of cells that underwent mitosis when stimulated 
with  insulin  in  medium  containing  low  concentrations  of 
serum. The range of possible phenotypes that could arise from 
this selection is quite broad• The use of inhibitors of micro- 
tubule polymerization has previously yielded density revert- 
ants of simian virus 40  (SV40)-transformed 3T3  cells (57), 
variants  of 3T3  cells  that  are  unresponsive  to  EGF  (39), 
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variants of 3T3 cells that have altered binding of insulin (58), 
and variants of 3T3 cells that do not respond to the tumor 
promoter  12-O-tetradecanoylphorbol-13-acetate  (59).  The 
presence of agents that destabilize microtubules has actually 
been shown to enhance the effect of growth factors in dense 
cultures of 3T3 cells (60, 61). None of the variants described 
here were resistant to colchicine. 
One class of variants that survived the present selection had 
a  drastically reduced  ability to  grow  in  medium with  low 
concentrations of serum. The lesion in these variants appeared 
to relate specifically to serum requirement, since all clones in 
this  class grew as rapidly as the  parental  cells in  medium 
containing high serum concentrations. In medium containing 
limiting serum concentrations the variants exhibited a weak 
growth response to insulin and PDGF, in that a relatively low 
proportion of cells were stimulated to traverse S  phase by 
addition  of insulin  or  PDGF.  The  fact that  only  a  small 
fraction of the variant cells entered the cell cycle in medium 
containing low concentrations of serum plus insulin explains 
the selective advantage of the variants under the conditions used for their isolation.  Addition  of insulin  and  PDGF to 
medium containing limiting serum concentrations resulted in 
a  more than  additive effect in  the  variants; however, even 
with high concentrations of insulin and PDGF, <50% of the 
variant cells entered S phase. 
The nuclear labeling experiments were complicated by the 
presence of serum, which contains both PDGF (1) and insu- 
lin-like growth factors (6-9). Thus, it was not possible to say 
with certainty which growth factor was actually limiting in a 
given experiment. To circumvent this problem, we studied in 
detail the growth of the the parental  100A cells and the INS 
471  variant, which had the "tightest" LS- phenotype (Fig. 4), 
in  hormone-supplemented serum-free media.  The  parental 
100A  cells  grew  extremely well  in  a  medium  containing 
fibronectin, transferrin, insulin, and PDGF. The parental cells 
also  grew well  in  a  similar  medium  in  which  PDGF  was 
replaced with EGF, although less growth was obtained in this 
medium than in the PDGF-containing medium. In the hor- 
mone-supplemented serum-free medium, no obvious differ- 
ence was detected between the growth response to insulin of 
the parental  100A  cells and the INS 471  variant cells.  The 
INS 471  variant cells did,  however, exhibit a  dramatically 
reduced growth response to PDGF. This defect in the growth 
response to  PDGF of the  variant cells was specific,  as the 
variant cells did not exhibit a  decreased growth response to 
EGF. The PDGF dose-response curve obtained with the INS 
471 variant was shifted to the right by approximately an order 
of magnitude in PDGF concentration relative to the PDGF 
dose-response curve obtained with the 100A parent. This very 
likely explains the requirement of  the variant for higher serum 
concentrations. Also, the decreased saturation density of the 
variant in serum-containing medium (Table II) is consistent 
with the variant having a defective growth response to PDGF, 
since PDGF appears to be the major serum determinant of 
saturation density (1). 
The genetic basis for the  phenotype of the variants is a 
subject of considerable interest. Two of the three variants had 
chromosome numbers that were approximately double that 
of the parental  100A  cells.  This hyperploidy very likely re- 
sulted from the use of colchicine in the selection procedure. 
Interestingly, when Pollack, Vogel, and co-workers (57,  62- 
64)  selected  flat revertants of SV40-transformed 3T3  cells, 
hyperploidy was associated with suppression of the ability to 
grow in low amounts of serum and low saturation density. 
Revertants picked on the basis of increased serum require- 
ment were always density revertants, but the opposite was not 
true (62,  63).  In the  present  study,  hyperploidy was not a 
necessary  condition  for  increased  serum  dependence.  For 
example, INS 643  had an increased serum dependence but 
had  a  modal  chromosome  number  similar to  that  of the 
parental  100A  cells.  A  comparison of the hormonal growth 
factor  requirements  of  SV40-transformed  3T3  ceils  and 
serum-dependent revertants of  these cells under totally serum- 
free conditions has not been reported. However, in experi- 
ments in which cells were plated in medium containing serum 
or on serum-coated dishes and then transferred to serum-free 
medium,  serum-dependent revertants of SV40-transformed 
3T3 cells appeared to have an increased insulin requirement 
(31).  In contrast, the principal defect in the INS 471  variant 
appears to be a poor growth response to PDGF. 
In  the  experiment shown  in  Table  IV, the  variant  cells 
exhibited, if anything, increased specific binding of the ~25I- 
PDGF tracer relative to the parental  100A cells.  This obser- 
vation  would  not  be  consistent  with  a  lesion  involving  a 
decrease in receptor number, with no alteration in receptor 
binding affinity. The binding data shown in Table IV would 
be consistent with other types of  defects in the PDGF receptor, 
or a postreceptor defect in the intracellular pathway of PDGF 
action. 
The base analogue 5-azaC, which reverts INS 471 at a high 
frequency, is known to cause hypomethylation of DNA (51) 
and reexpression of the genes that have been inactivated by 
DNA methylation. Genes that have previously been found to 
be activated by 5-azaC, possibly by a  mechanism involving 
hypomethylation, include a cryptic metallothionein-I gene in 
W7  mouse  thymoma  cells  (53),  genes  on  an  inactive  X 
chromosome (52), endogenous retroviral genes (54), an inac- 
tive thymidine kinase gene in a  thymidine kinase.deficient 
variant hamster cell  line  (55),  and  developmentally inacti- 
vated fetal globin genes (65).  5-azaC also induces malignant 
transformation of cultured C3H 10TI/2 cells (66) and CHEF/ 
18 cells (67), and 5-azaC is a carcinogen that induces leuke- 
mias and lymphomas in mice when assayed by the standard 
National Cancer Institute bioassay protocol (68). This suggests 
that 5-azaC is capable of activating cellular oncogenes in some 
cell types. 
The very high frequency of reversion of INS 471  induced 
by 5-azaC, compared with the low reversion frequency in- 
duced by EMS, suggested that 5-azaC reverted INS 471  by a 
nonmutational  mechanism,  possibly involving a  change in 
DNA methylation. In parallel control experiments in which 
forward mutation to ouabain resistance was measured with 
the same doses of 5-azaC and EMS,  a  strong induction  of 
ouabain-resistant mutants was observed with EMS but  not 
with  5-azaC.  This is consistent with  the  known  mutagenic 
potency of the two chemicals: EMS is a very strong mutagen 
(48, 49), whereas 5-azaC is a very weak one (50). The extraor- 
dinarily high frequency of reversion of INS 471  induced by 
5-azaC (nearly 1% at a dose of 3 ~g/ml) is also suggestive of 
reversion by a nonmutational mechanism. 
The  INS  471  variant  arose  in  a  culture  that  had  been 
mutagenized by EMS. EMS is primarily a base pair substitu- 
tion mutagen (69), and no effect of  EMS on DNA methylation 
has  been  described  to  date.  Thus,  reversion  of an  EMS- 
induced mutant with 5-azaC is a surprising observation. One 
similar example of EMS-induced variants that are reverted at 
a high frequency by 5-azaC has been reported recently: these 
are prolactin-deficient variants of the rat GH3 cell line (70). 
There are a number of possible explanations for the reversion 
characteristics of the INS 471  cell line. The principal lesion 
in this variant could involve methylation of a regulatory site 
of a gene involved in the PDGF response, which is reverted 
by treatment of  the variant by 5-azaC. Alternatively, the lesion 
in INS 471  could be a  true mutation that is reverted by 5- 
azaC-induced demethylation at a second rite. The identity of 
genes involved in regulating the cellular response to PDGF 
and other growth factors is a subject of considerable current 
interest. Recently, PDGF has been shown to regulate several 
specific messenger RNAs, including transcripts of the c-myc 
gene (71-73). It will be of considerable interest to determine 
whether there is a defect in the induction by PDGF of any of 
these mRNAs in the INS 471 variant. 
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